annual ROE:
-87.35%-40.90%(-88.05%)Summary
- As of today (August 21, 2025), SLNO annual return on equity is -87.35%, with the most recent change of -40.90% (-88.05%) on December 31, 2024.
- During the last 3 years, SLNO annual ROE has risen by +10.25% (+10.50%).
- SLNO annual ROE is now -165.05% below its all-time high of 134.28%, reached on December 31, 2014.
Performance
SLNO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-71.69%+13.30%(+15.65%)Summary
- As of today (August 21, 2025), SLNO quarterly return on equity is -71.69%, with the most recent change of +13.30% (+15.65%) on June 30, 2025.
- Over the past year, SLNO quarterly ROE has dropped by -18.71% (-35.32%).
- SLNO quarterly ROE is now -119.16% below its all-time high of 374.26%, reached on December 31, 2015.
Performance
SLNO quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SLNO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.0% | -35.3% |
| 3 y3 years | +10.5% | +31.3% |
| 5 y5 years | +35.6% | +41.9% |
SLNO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.0% | +48.9% | -35.3% | +72.4% |
| 5 y | 5-year | -88.0% | +48.9% | -35.3% | +72.4% |
| alltime | all time | -165.1% | +82.3% | -119.2% | +99.7% |
SLNO ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -71.69%(-15.6%) |
| Mar 2025 | - | -84.99%(+5.5%) |
| Dec 2024 | -87.35%(+88.1%) | -80.56%(+6.8%) |
| Sep 2024 | - | -75.42%(+42.4%) |
| Jun 2024 | - | -52.98%(-30.9%) |
| Mar 2024 | - | -76.70%(-18.9%) |
| Dec 2023 | -46.45%(-72.8%) | -94.57%(-63.6%) |
| Sep 2023 | - | -259.88%(+11.3%) |
| Jun 2023 | - | -233.49%(+31.1%) |
| Mar 2023 | - | -178.10%(+33.4%) |
| Dec 2022 | -171.05%(+75.3%) | -133.54%(+24.7%) |
| Sep 2022 | - | -107.08%(+2.6%) |
| Jun 2022 | - | -104.35%(-2.4%) |
| Mar 2022 | - | -106.90%(+2.7%) |
| Dec 2021 | -97.60%(+19.8%) | -104.04%(+20.2%) |
| Sep 2021 | - | -86.52%(+18.6%) |
| Jun 2021 | - | -72.97%(+3.5%) |
| Mar 2021 | - | -70.47%(-0.4%) |
| Dec 2020 | -81.46%(-40.0%) | -70.74%(-44.2%) |
| Sep 2020 | - | -126.87%(+2.8%) |
| Jun 2020 | - | -123.38%(-36.0%) |
| Mar 2020 | - | -192.75%(+22.4%) |
| Dec 2019 | -135.69% | -157.46%(+93.8%) |
| Sep 2019 | - | -81.24%(-16.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -96.77%(+33.0%) |
| Mar 2019 | - | -72.74%(+35.5%) |
| Dec 2018 | -41.38%(-46.9%) | -53.68%(-32.6%) |
| Sep 2018 | - | -79.70%(+10.9%) |
| Jun 2018 | - | -71.89%(+43.2%) |
| Mar 2018 | - | -50.19%(-6.1%) |
| Dec 2017 | -77.96%(-75.0%) | -53.46%(-6.6%) |
| Sep 2017 | - | -57.22%(-17.3%) |
| Jun 2017 | - | -69.19%(-25.0%) |
| Mar 2017 | - | -92.20%(-61.4%) |
| Dec 2016 | -312.02%(-36.8%) | -238.91%(-24.5%) |
| Sep 2016 | - | -316.31%(-85.2%) |
| Jun 2016 | - | -2130.21%(-90.4%) |
| Mar 2016 | - | -22.09K%(-6003.6%) |
| Dec 2015 | -493.47%(-467.5%) | 374.26%(+36.7%) |
| Sep 2015 | - | 273.80%(+63.6%) |
| Jun 2015 | - | 167.37%(-4.2%) |
| Mar 2015 | - | 174.72%(+89.2%) |
| Dec 2014 | 134.28%(+409.2%) | 92.34%(+236.0%) |
| Sep 2014 | - | 27.48%(+74.5%) |
| Jun 2014 | - | 15.75%(+38.9%) |
| Mar 2014 | - | 11.34%(+275.5%) |
| Dec 2013 | 26.37%(-57.7%) | 3.02% |
| Dec 2012 | 62.40% | - |
FAQ
- What is Soleno Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual ROE year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly ROE year-on-year change?
What is Soleno Therapeutics, Inc. annual return on equity?
The current annual ROE of SLNO is -87.35%
What is the all time high annual ROE for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual return on equity is 134.28%
What is Soleno Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, SLNO annual return on equity has changed by -40.90% (-88.05%)
What is Soleno Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of SLNO is -71.69%
What is the all time high quarterly ROE for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly return on equity is 374.26%
What is Soleno Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, SLNO quarterly return on equity has changed by -18.71% (-35.32%)